Cite
Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia.
MLA
Kiani-Zadeh, Masoumeh, et al. “Studying the Potential of Upregulated PTGS2 and VEGF-C besides Hyper-Methylation of PTGS2 Promoter as Biomarkers of Acute Myeloid Leukemia.” Molecular Biology Reports, vol. 49, no. 8, Aug. 2022, pp. 7849–62. EBSCOhost, https://doi.org/10.1007/s11033-022-07615-7.
APA
Kiani-Zadeh, M., Rezvany, M. R., Namjoo, S., Barati, M., Mohammadi, M. H., Ghasemi, B., Tabatabaei, T., Ghavamzadeh, A., Zaker, F., & Teimoori-Toolabi, L. (2022). Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia. Molecular Biology Reports, 49(8), 7849–7862. https://doi.org/10.1007/s11033-022-07615-7
Chicago
Kiani-Zadeh, Masoumeh, Mohammad Reza Rezvany, Soodeh Namjoo, Mahmood Barati, Mohammad Hossein Mohammadi, Bahare Ghasemi, Tahere Tabatabaei, Ardeshir Ghavamzadeh, Farhad Zaker, and Ladan Teimoori-Toolabi. 2022. “Studying the Potential of Upregulated PTGS2 and VEGF-C besides Hyper-Methylation of PTGS2 Promoter as Biomarkers of Acute Myeloid Leukemia.” Molecular Biology Reports 49 (8): 7849–62. doi:10.1007/s11033-022-07615-7.